Rakuten Securities’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Rakuten Securities's IBB Position: Q2 2026 in Review
Rakuten Securities reduced its iShares Biotechnology ETF (IBB) stake by 29% in Q2 2026, selling an estimated $17.2K and leaving 250 shares worth $47.5K. The position accounts for 0.01% of the portfolio, ranked #272.
Rakuten Securities first reported a position in IBB in Q1 2024 and has held it in 10 quarters since. The position peaked at $59.1K in Q1 2026. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Rakuten Securities held 250 shares of iShares Biotechnology ETF worth $47.5K as of Q2 2026.
- Rakuten Securities sold 100 iShares Biotechnology ETF shares in Q2 2026, an estimated $17.2K.
- iShares Biotechnology ETF made up 0.01% of Rakuten Securities's portfolio in Q2 2026, its #272 holding.
- Rakuten Securities first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 10 quarters since.
- Rakuten Securities's iShares Biotechnology ETF position peaked at $59.1K in Q1 2026.
- 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.